RNC Capital Management LLC Cuts Position in UnitedHealth Group Incorporated $UNH

RNC Capital Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 25.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,005 shares of the healthcare conglomerate’s stock after selling 6,528 shares during the period. RNC Capital Management LLC’s holdings in UnitedHealth Group were worth $6,274,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Christine Messmer PC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $258,000. Falcon Wealth Planning raised its holdings in shares of UnitedHealth Group by 15.1% during the 4th quarter. Falcon Wealth Planning now owns 1,535 shares of the healthcare conglomerate’s stock valued at $507,000 after buying an additional 201 shares during the period. American Financial Advisors LLC raised its holdings in shares of UnitedHealth Group by 12.3% during the 4th quarter. American Financial Advisors LLC now owns 766 shares of the healthcare conglomerate’s stock valued at $253,000 after buying an additional 84 shares during the period. Nicholas Hoffman & Company LLC. raised its holdings in shares of UnitedHealth Group by 1.8% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 2,533 shares of the healthcare conglomerate’s stock valued at $836,000 after buying an additional 44 shares during the period. Finally, Alliance Wealth Advisors LLC UT raised its holdings in shares of UnitedHealth Group by 13.4% during the 4th quarter. Alliance Wealth Advisors LLC UT now owns 797 shares of the healthcare conglomerate’s stock valued at $263,000 after buying an additional 94 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare will eliminate prior-authorization requirements for roughly 30% of services, a move designed to simplify access, reduce administrative friction and improve member/provider satisfaction — a potential competitive and reputational positive for UNH. UnitedHealthcare Cuts Prior Authorization Requirements by 30%
• Positive Sentiment: UnitedHealth reported a Q1 revenue and EPS beat and issued stronger FY guidance, underscoring continued top-line scale and profit conversion that support the stock’s valuation. This was a primary driver of bullish investor reaction. How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge
• Positive Sentiment: Coverage highlights UNH’s push to deploy AI to streamline operations and lower costs — a strategic tailwind for margins if execution continues delivering efficiency gains. Is UnitedHealth Stock a Generational Buying Opportunity?
• Neutral Sentiment: Analyst and media pieces note UNH’s large-cap status, dividend and valuation trade-offs — useful framing for income and long-term investors but not immediate catalysts. How to buy a major Dow component, at a discount
• Negative Sentiment: Shareholders face a governance proposal from The Accountability Board seeking an independent chair; UNH’s management urged a vote against it — this raises oversight/governance risk that some investors view negatively. How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective on the stock in a report on Tuesday, April 7th. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Sanford C. Bernstein upped their target price on UnitedHealth Group from $405.00 to $411.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Finally, Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 target price on the stock in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $378.88.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

UNH stock opened at $369.91 on Tuesday. The firm has a market cap of $335.96 billion, a P/E ratio of 27.94, a P/E/G ratio of 1.59 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $409.70. The stock’s 50 day simple moving average is $299.45 and its 200 day simple moving average is $316.79. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. During the same period last year, the company earned $7.20 earnings per share. The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 66.77%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.